133 related articles for article (PubMed ID: 1313031)
1. Inhibition of tissue kallikrein by protein C inhibitor. Evidence for identity of protein C inhibitor with the kallikrein binding protein.
Ecke S; Geiger M; Resch I; Jerabek I; Sting L; Maier M; Binder BR
J Biol Chem; 1992 Apr; 267(10):7048-52. PubMed ID: 1313031
[TBL] [Abstract][Full Text] [Related]
2. Possible identity of kallikrein binding protein with protein C inhibitor.
Ecke S; Geiger M; Resch I; Jerabek I; Maier M; Binder BR
Agents Actions Suppl; 1992; 38 ( Pt 1)():182-9. PubMed ID: 1334618
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of human plasma kallikrein and factor XIa by protein C inhibitor.
Meijers JC; Kanters DH; Vlooswijk RA; van Erp HE; Hessing M; Bouma BN
Biochemistry; 1988 Jun; 27(12):4231-7. PubMed ID: 2844223
[TBL] [Abstract][Full Text] [Related]
4. Vitronectin modulates glycosaminoglycan dependent reactions of protein C inhibitor.
Seiffert D; Geiger M; Ecke S; Binder BR
Thromb Haemost; 1992 Dec; 68(6):657-61. PubMed ID: 1283793
[TBL] [Abstract][Full Text] [Related]
5. Heparin binding of protein-C inhibitor--analysis of the effect of heparin on the interaction of protein-C inhibitor with tissue kallikrein.
Ecke S; Geiger M; Binder BR
Eur J Biochem; 1997 Sep; 248(2):475-80. PubMed ID: 9346305
[TBL] [Abstract][Full Text] [Related]
6. Purification and characterization of plasma protein C inhibitor.
España F; Berrettini M; Griffin JH
Thromb Res; 1989 Aug; 55(3):369-84. PubMed ID: 2551064
[TBL] [Abstract][Full Text] [Related]
7. High molecular weight kininogen potentiates the heparin-accelerated inhibition of plasma kallikrein by antithrombin: role for antithrombin in the regulation of kallikrein.
Olson ST; Sheffer R; Francis AM
Biochemistry; 1993 Nov; 32(45):12136-47. PubMed ID: 7692967
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of kallikrein in human plasma.
van der Graaf F; Koedam JA; Bouma BN
J Clin Invest; 1983 Jan; 71(1):149-58. PubMed ID: 6184384
[TBL] [Abstract][Full Text] [Related]
9. Protein C inhibitor from human plasma: characterization of native and cleaved inhibitor and demonstration of inhibitor complexes with plasma kallikrein.
Laurell M; Stenflo J
Thromb Haemost; 1989 Nov; 62(3):885-91. PubMed ID: 2556811
[TBL] [Abstract][Full Text] [Related]
10. Urinary protein C inhibitor. Glycosaminoclycans synthesized by the epithelial kidney cell line TCL-598 enhance its interaction with urokinase.
Geiger M; Priglinger U; Griffin JH; Binder BR
J Biol Chem; 1991 Jun; 266(18):11851-7. PubMed ID: 1646816
[TBL] [Abstract][Full Text] [Related]
11. Complexes of tissue kallikrein with protein C inhibitor in human semen and urine.
España F; Fink E; Sanchez-Cuenca J; Gilabert J; Estellés A; Witzgall K
Eur J Biochem; 1995 Dec; 234(2):641-9. PubMed ID: 8536714
[TBL] [Abstract][Full Text] [Related]
12. Binding of urinary protein C inhibitor to cultured human epithelial kidney tumor cells (TCL-598). The role of glycosaminoglycans present on the luminal cell surface.
Priglinger U; Geiger M; Bielek E; Vanyek E; Binder BR
J Biol Chem; 1994 May; 269(20):14705-10. PubMed ID: 8182078
[TBL] [Abstract][Full Text] [Related]
13. Interaction of plasma kallikrein with protein C inhibitor in purified mixtures and in plasma.
España F; Estelles A; Griffin JH; Aznar J
Thromb Haemost; 1991 Jan; 65(1):46-51. PubMed ID: 1850876
[TBL] [Abstract][Full Text] [Related]
14. Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3.
Heeb MJ; España F; Geiger M; Collen D; Stump DC; Griffin JH
J Biol Chem; 1987 Nov; 262(33):15813-6. PubMed ID: 2824468
[TBL] [Abstract][Full Text] [Related]
15. A new and simple isolation procedure for human protein C inhibitor. Evidence for a second inhibitor for activated protein C present in human plasma.
Radtke KP; Stief TW; Heimburger N
Biol Chem Hoppe Seyler; 1988 Sep; 369(9):965-74. PubMed ID: 2852498
[TBL] [Abstract][Full Text] [Related]
16. Identification of a new tissue-kallikrein-binding protein.
Chao J; Tillman DM; Wang MY; Margolius HS; Chao L
Biochem J; 1986 Oct; 239(2):325-31. PubMed ID: 3643793
[TBL] [Abstract][Full Text] [Related]
17. Basic residues in the 37-loop of activated protein C modulate inhibition by protein C inhibitor but not by alpha(1)-antitrypsin.
Glasscock LN; Gerlitz B; Cooper ST; Grinnell BW; Church FC
Biochim Biophys Acta; 2003 Jun; 1649(1):106-17. PubMed ID: 12818196
[TBL] [Abstract][Full Text] [Related]
18. Kallistatin: a novel human tissue kallikrein inhibitor. Purification, characterization, and reactive center sequence.
Zhou GX; Chao L; Chao J
J Biol Chem; 1992 Dec; 267(36):25873-80. PubMed ID: 1334488
[TBL] [Abstract][Full Text] [Related]
19. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
[TBL] [Abstract][Full Text] [Related]
20. The major plasma kallikrein inhibitor of guinea pig plasma.
Imamura T; Kambara T
Biochim Biophys Acta; 1992 Feb; 1118(3):261-6. PubMed ID: 1737048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
